Partnering & Investing
Drug development means giving hope to patients suffering from very serious diseases. Our vision is to realize this hope by developing highly needed treatments. Be part of our journey!
We are open for any kind of cooperation. Please contact us if you need more information about our development programs. Priavoid is regularly visiting the relevant trade fairs and congresses. Our representatives look forward to meeting you. You can find an up-to-date overview of planned trade fairs and congresses under Events.
“Coming together is a beginning, staying together is progress, working together is success.”
Priavoid GmbH is a privately held company financed via venture capital. Our Alzheimer's program PRI-002 is also funded through a research collaboration with Prinnovation GmbH via the German Federal Agency for Disruptive Innovation (SPRIN-D). Furthermore, we have received funding from the Michael J. Fox Foundation for the Parkinson's disease program PRI-100.
Since drug development is capital-intensive, we plan to conduct financing rounds in the future as well. If you are interested in participating, please contact our management.